Related Experiment Video
Updated: Mar 6, 2026

Application of Granger Causality Analysis of the Directed Functional Connection in Alzheimer's Disease and Mild Cognitive Impairment
Published on: August 7, 2017
A systematic study on the integration of MRI connectivity metrics for Alzheimer's diagnosis, staging, and cognitive
Shahzad Ali1,2,3, Wendy Kreshpa4,5, Nicola Rosso4
1Department of Pharmacy and Biotechnology, Alma Mater Studiorum - Universitá di Bologna, Bologna, Italy.
Abstract:
Alzheimer's disease (AD) is a degenerative neurological disorder marked by cognitive decline and functional disability. Despite the extensive use of magnetic resonance imaging (MRI) in machine learning (ML)-based AD studies, the relative and combined contributions of MRI-derived morphometric (MO), microstructural (MS), and graph-theoretical (GT) features are still not well explored in a unified, comparative framework. It remains unclear whether adding multimodal MRI-derived features consistently improves the predictive performance of ML-based approaches for AD diagnosis and cognitive decline. Addressing this gap, this study systematically analyzed the individual (MO, MS, GT) and combined (MO+MS, MO+GT, MS+GT, MO+MS+GT) utility of MRI-based feature sets. We developed an ensemble-based ML framework with a nested cross-validation module for two key tasks: (i) Alzheimer's disease cognitive stage classification (DSC) and (ii) longitudinal cognitive decline prediction (LCDP) in terms of mini-mental state examination (MMSE) score. In this study, we conducted feature ablation and statistical analysis to evaluate performance improvements resulting from the incremental addition of feature sets. The results of the study indicated that the proposed ensemble-based ML approach achieved the best predictive performance (balanced accuracy [BACC]: 0.898 ± 0.051) using a combination of MO and MS feature sets for cognitively normal (CN) vs. AD dementia (CN-ADD). In contrast, the best results for mild cognitive impairment (MCI) vs. ADD (MCI-ADD) and CN-MCI were achieved using the MO feature set alone, with BACC of 0.769 ± 0.116 and 0.652 ± 0.044, respectively. Likewise, for the LCDP task, the MO-based ensemble learner achieved an R2 of 0.212 ± 0.177. These results demonstrate that MO features capture the most robust disease-related information, while multimodal integration offers task-specific and limited benefits. In addition, these findings demonstrate the potential of integrated MRI-derived features in ML frameworks for enhancing ADD diagnosis and cognitive decline prediction and underscore the importance of feature selection based on task complexity.
Insights
This study reveals that morphometric (MO) MRI features are most effective for diagnosing Alzheimer's disease (AD) and predicting cognitive decline using machine learning. Combining different MRI features offers limited benefits, highlighting the importance of feature selection.
Area of Science:
- Neuroimaging
- Machine Learning
- Neurology
Background:
- Alzheimer's disease (AD) is a neurodegenerative disorder causing cognitive decline.
- Machine learning (ML) uses magnetic resonance imaging (MRI) for AD studies, but the combined utility of different MRI features is unclear.
- Predictive performance for AD diagnosis and cognitive decline prediction needs improvement.
Purpose of the Study:
- To systematically analyze the individual and combined utility of MRI-derived morphometric (MO), microstructural (MS), and graph-theoretical (GT) features.
- To develop an ensemble-based ML framework for Alzheimer's disease cognitive stage classification (DSC) and longitudinal cognitive decline prediction (LCDP).
- To evaluate the impact of multimodal MRI feature integration on ML model performance.
Main Methods:
- An ensemble-based ML framework with nested cross-validation was developed.
- Feature ablation and statistical analysis were used to assess performance.
- Individual (MO, MS, GT) and combined (MO+MS, MO+GT, MS+GT, MO+MS+GT) feature sets were analyzed.
Main Results:
- The best predictive performance for cognitively normal (CN) vs. AD dementia (ADD) was achieved using MO+MS features (BACC: 0.898 ± 0.051).
- MO features alone yielded the best results for mild cognitive impairment (MCI) vs. ADD (BACC: 0.769 ± 0.116) and CN vs. MCI (BACC: 0.652 ± 0.044).
- For LCDP, MO features achieved an R² of 0.212 ± 0.177.
Conclusions:
- Morphometric (MO) MRI features capture the most robust disease-related information for Alzheimer's disease.
- Multimodal MRI feature integration provides task-specific, limited benefits.
- Feature selection based on task complexity is crucial for optimizing ML models in AD research.
More Related Videos
12:50Lesion Explorer: A Video-guided, Standardized Protocol for Accurate and Reliable MRI-derived Volumetrics in Alzheimer's Disease and Normal Elderly
Published on: April 14, 2014
09:38Generalized Psychophysiological Interaction PPI Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease
Published on: November 14, 2017